SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

20 May 2025 Evaluate
The Turnover for the quarter ended March 2025 of Rs. 58196.00 millions increase by 74.64% from Rs. 33324.00 millions.Net Profit witnessed a 100.23% growth almost the double from Rs. 14052.00 millions to Rs. 28137.00  millions  of same quarter last year.Operating profit surged to 39581.00 millions from the corresponding previous quarter of 19303.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 58196.00 33324.00 74.64 151163.00 108187.00 39.72 151163.00 108187.00 39.72
Other Income 1854.00 3688.00 -49.73 9058.00 11595.00 -21.88 9058.00 11595.00 -21.88
PBIDT 39581.00 19303.00 105.05 84325.00 51435.00 63.94 84325.00 51435.00 63.94
Interest 1554.00 1062.00 46.33 4639.00 3907.00 18.74 4639.00 3907.00 18.74
PBDT 38027.00 18155.00 109.46 79686.00 47442.00 67.97 79686.00 47442.00 67.97
Depreciation 1280.00 1306.00 -1.99 5239.00 5044.00 3.87 5239.00 5044.00 3.87
PBT 36747.00 16849.00 118.10 74447.00 42398.00 75.59 74447.00 42398.00 75.59
TAX 8610.00 2797.00 207.83 16698.00 7983.00 109.17 16698.00 7983.00 109.17
Deferred Tax 345.00 -1278.00 -127.00 873.00 -1360.00 -164.19 873.00 -1360.00 -164.19
PAT 28137.00 14052.00 100.23 57749.00 34415.00 67.80 57749.00 34415.00 67.80
Equity 1006.00 1006.00 0.00 1006.00 1006.00 0.00 1006.00 1006.00 0.00
PBIDTM(%) 68.01 57.93 17.42 55.78 47.54 17.33 55.78 47.54 17.33

Zydus Lifesciences Share Price

938.90 -1.20 (-0.13%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×